These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7594335)

  • 61. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
    Avner DL; Movva R; Nelson KJ; McFarland M; Berry W; Erfling W
    Am J Gastroenterol; 1995 Aug; 90(8):1289-94. PubMed ID: 7639232
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
    Yoshino J; Nakazawa S; Nakamura T; Yamao K; Inui K; Yamachika H; Watanabe K; Wakabayashi T
    Nihon Rinsho; 1992 Jan; 50(1):81-5. PubMed ID: 1347334
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
    Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C
    Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
    Kuwayama H; Matsuo Y; Eastwood GL
    Am J Med; 1991 Aug; 91(2A):15S-19S. PubMed ID: 1882902
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
    Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
    Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Takeda H; Hokari K; Asaka M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
    Graham DY; Agrawal NM; Campbell DR; Haber MM; Collis C; Lukasik NL; Huang B;
    Arch Intern Med; 2002 Jan; 162(2):169-75. PubMed ID: 11802750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quality of peptic ulcer healing induced by lansoprazole and roxatidine.
    Fujino MA; Morozumi A; Kobayashi K; Ueda F; Suzuki Y; Uchida N; Tachikawa H; Sano S; Ohtsuka H; Yamamoto Y
    J Clin Gastroenterol; 1995; 20 Suppl 2():S44-6. PubMed ID: 7594338
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia.
    Imaeda H; Hosoe N; Suzuki H; Saito Y; Ida Y; Nakamura R; Iwao Y; Ogata H; Hibi T
    J Gastroenterol; 2011 Nov; 46(11):1267-72. PubMed ID: 21805066
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Treatment of NSAIDs induced ulcers].
    Mizokami Y; Shiraishi T; Otsubo T; Nakamura H; Miyazawa K; Narushima K; Matsuoka T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():567-71. PubMed ID: 11979847
    [No Abstract]   [Full Text] [Related]  

  • 80. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
    Hawkey CJ; Long RG; Bardhan KD; Wormsley KG; Cochran KM; Christian J; Moules IK
    Gut; 1993 Oct; 34(10):1458-62. PubMed ID: 8244121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.